Byrne Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.4K | Buy |
2,148
+899
| +72% | +$41.6K | 0.07% | 156 |
|
|
2025
Q1 | $76.2K | Hold |
1,249
| – | – | 0.06% | 169 |
|
|
2024
Q4 | $70.6K | Buy |
1,249
+75
| +6% | +$4.24K | 0.05% | 174 |
|
|
2024
Q3 | $60.7K | Sell |
1,174
-320
| -21% | -$16.6K | 0.04% | 186 |
|
|
2024
Q2 | $62K | Sell |
1,494
-234
| -14% | -$9.71K | 0.04% | 185 |
|
|
2024
Q1 | $93.7K | Sell |
1,728
-415
| -19% | -$22.5K | 0.06% | 160 |
|
|
2023
Q4 | $110K | Sell |
2,143
-937
| -30% | -$48K | 0.08% | 141 |
|
|
2023
Q3 | $179K | Sell |
3,080
-30
| -1% | -$1.74K | 0.15% | 110 |
|
|
2023
Q2 | $199K | Sell |
3,110
-85
| -3% | -$5.44K | 0.13% | 144 |
|
|
2023
Q1 | $221K | Sell |
3,195
-1,000
| -24% | -$69.2K | 0.16% | 126 |
|
|
2022
Q4 | $302K | Sell |
4,195
-1,144
| -21% | -$82.3K | 0.22% | 108 |
|
|
2022
Q3 | $380K | Sell |
5,339
-210
| -4% | -$14.9K | 0.29% | 94 |
|
|
2022
Q2 | $427K | Buy |
5,549
+4,198
| +311% | +$323K | 0.32% | 76 |
|
|
2022
Q1 | $99K | Sell |
1,351
-73
| -5% | -$5.35K | 0.06% | 164 |
|
|
2021
Q4 | $89K | Buy |
+1,424
| New | +$89K | 0.06% | 178 |
|